Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Fasting on the Non-invasive Measurement of the Body's Water Compartments

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04665349
Recruitment Status : Completed
First Posted : December 11, 2020
Last Update Posted : December 11, 2020
Sponsor:
Information provided by (Responsible Party):
Radosław Owczuk, Medical University of Gdansk

Brief Summary:

Preoperative fasting is defined as refraining from food for at least 6 hours and clear fluids for at least 2 hours prior to anaesthesia. On the one hand, it is a procedure that reduces the risk of aspiration of food content and the occurrence of Mendelson's syndrome, and on the other hand, it was considered to be the cause of disturbances in water management in patients undergoing general anaesthesia. However, reports from recent years have found that moderate preoperative fasting does not influence the risk of hypovolemia in anesthetized patients. It is also known that in fasting people the total body water is reduced. Thus, it can be assumed that there are mechanisms causing the movement of extravascular water into the lumen of blood vessels. For several years, the Body Composition Monitor (BCM) device for non-invasive measurement of the volume of individual water compartments of the human body has been available on the market. It allows to determine the volume of total body water, intracellular body water and extracellular body water. It is mainly used during dialysis, but it can also be used in other circumstances that require the determination of the body's hydration status. The principle of this method is based on non-invasive bioimpedance measurement with the use of 4 electrodes placed on two extremities.

The aim of the study is to determine whether there is a fluid shift between the intracellular and extracellular compartments in people undergoing preoperative fasting. Examination of this issue would allow for the development of hypothesis regarding the optimal perioperative fluid therapy. If there was a shift of fluid from the intracellular space, it seems more rational to supplement fluid deficiencies resulting from starvation with a 5% glucose solution. If, on the other hand, no fluid shift from the intracellular space was detected, which would suggest shifts within the extracellular space, it would be advisable to hydrate the patient with crystalloid solutions.


Condition or disease Intervention/treatment Phase
Dehydration Perioperative Complication Dietary Supplement: Nutricia Pre-op, 400 milliliters, per os Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 81 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Effect of Fasting on the Non-invasive Measurement of the Body's Water Compartments
Actual Study Start Date : November 20, 2019
Actual Primary Completion Date : October 12, 2020
Actual Study Completion Date : October 13, 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Drinking Water

Arm Intervention/treatment
Experimental: Pre-op
Nutricia Pre-op, 400 milliliters, per os
Dietary Supplement: Nutricia Pre-op, 400 milliliters, per os
After 10 hours of fasting participants will receive per os 400 milliliters of Nutricia Pre-op

No Intervention: Control
No intervention



Primary Outcome Measures :
  1. Amount of total body water [ Time Frame: Changes form baseline after 10 hours of fasting and after 2 hours of pre-op administration ]
    Measurements will be done with Fresenius Body Composition Monitor

  2. Extracellular to intracellular water ratio [ Time Frame: Changes form baseline after 10 hours of fasting and after 2 hours of pre-op administration ]
    Measurements will be done with Fresenius Body Composition Monitor



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 40 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • American Society of Anesthesiology (ASA) general condition assessment 1 or 2

Exclusion Criteria:

  • Chronic kidney disease
  • Circulatory failure
  • Phenylketonuria
  • History of hypoglycaemic episodes or any carbohydrate metabolism disorders.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04665349


Locations
Layout table for location information
Poland
Medical University of Gdansk - Departament of Anesthesiology and Intensive Care
Gdańsk, Pomorskie, Poland, 80-210
Sponsors and Collaborators
Medical University of Gdansk
Investigators
Layout table for investigator information
Principal Investigator: Radosław Owczuk, Professor Medical University of Gdansk
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Radosław Owczuk, Clinical Professor, Head of Department of Anaesthesiology and Intensive Care, Medical University of Gdansk
ClinicalTrials.gov Identifier: NCT04665349    
Other Study ID Numbers: NKBBN/126/2014
First Posted: December 11, 2020    Key Record Dates
Last Update Posted: December 11, 2020
Last Verified: December 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Dehydration
Water-Electrolyte Imbalance
Metabolic Diseases
Pathologic Processes